Morgan Stanley’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
83,019
-30,679
| -27% | -$39.9K | ﹤0.01% | 6099 |
|
|
2025
Q1 | $158K | Sell |
113,698
-16,071
| -12% | -$22.3K | ﹤0.01% | 5831 |
|
|
2024
Q4 | $297K | Sell |
129,769
-40,642
| -24% | -$93.1K | ﹤0.01% | 5636 |
|
|
2024
Q3 | $464K | Buy |
170,411
+62,227
| +58% | +$169K | ﹤0.01% | 5438 |
|
|
2024
Q2 | $253K | Buy |
108,184
+44,418
| +70% | +$104K | ﹤0.01% | 5576 |
|
|
2024
Q1 | $299K | Sell |
63,766
-109,832
| -63% | -$515K | ﹤0.01% | 5561 |
|
|
2023
Q4 | $847K | Buy |
173,598
+140,094
| +418% | +$684K | ﹤0.01% | 5377 |
|
|
2023
Q3 | $156K | Sell |
33,504
-3,716
| -10% | -$17.3K | ﹤0.01% | 5693 |
|
|
2023
Q2 | $275K | Buy |
37,220
+7,370
| +25% | +$54.5K | ﹤0.01% | 5502 |
|
|
2023
Q1 | $244K | Sell |
29,850
-13,350
| -31% | -$109K | ﹤0.01% | 5619 |
|
|
2022
Q4 | $413K | Sell |
43,200
-2,063
| -5% | -$19.7K | ﹤0.01% | 5334 |
|
|
2022
Q3 | $532K | Sell |
45,263
-5,433
| -11% | -$63.9K | ﹤0.01% | 5238 |
|
|
2022
Q2 | $651K | Buy |
50,696
+10,375
| +26% | +$133K | ﹤0.01% | 5278 |
|
|
2022
Q1 | $444K | Buy |
40,321
+11,786
| +41% | +$130K | ﹤0.01% | 5480 |
|
|
2021
Q4 | $436K | Sell |
28,535
-94,616
| -77% | -$1.45M | ﹤0.01% | 5626 |
|
|
2021
Q3 | $1.72M | Buy |
123,151
+12,649
| +11% | +$177K | ﹤0.01% | 4686 |
|
|
2021
Q2 | $2.14M | Buy |
+110,502
| New | +$2.14M | ﹤0.01% | 4579 |
|